ClinicalTrials.Veeva

Menu

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis (IBMan)

I

Institut de Myologie, France

Status

Completed

Conditions

Inclusion Body Myositis

Study type

Observational

Funder types

Other

Identifiers

NCT00898989
2009-a00055-52

Details and patient eligibility

About

Comparison of a group of 20 IBM patients with 20 controls matched on age, gender and weight.

Enrollment

42 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 18 years old
  • Written consent

Exclusion criteria

  • Current infection
  • Cancer within 1 year
  • Immune deficiency

Trial design

42 participants in 2 patient groups

Inclusion Body Myositis
Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems